These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7907650

  • 1. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
    Schmidt CJ, Sullivan CK, Fadayel GM.
    J Neurochem; 1994 Apr; 62(4):1382-9. PubMed ID: 7907650
    [Abstract] [Full Text] [Related]

  • 2. 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.
    Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL.
    Eur J Pharmacol; 1992 Nov 13; 223(1):65-74. PubMed ID: 1362159
    [Abstract] [Full Text] [Related]

  • 3. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.
    Nash JF.
    Life Sci; 1990 Nov 13; 47(26):2401-8. PubMed ID: 1979830
    [Abstract] [Full Text] [Related]

  • 4. The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.
    Schmidt CJ, Black CK, Taylor VL, Fadayel GM, Humphreys TM, Nieduzak TR, Sorensen SM.
    Eur J Pharmacol; 1992 Sep 22; 220(2-3):151-9. PubMed ID: 1425989
    [Abstract] [Full Text] [Related]

  • 5. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    Nash JF, Brodkin J.
    J Pharmacol Exp Ther; 1991 Nov 22; 259(2):820-5. PubMed ID: 1682486
    [Abstract] [Full Text] [Related]

  • 6. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK, Nash JF, Gudelsky GA.
    J Pharmacol Exp Ther; 1995 Jun 22; 273(3):1063-70. PubMed ID: 7791076
    [Abstract] [Full Text] [Related]

  • 7. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ, Abbate GM, Black CK, Taylor VL.
    J Pharmacol Exp Ther; 1990 Nov 22; 255(2):478-83. PubMed ID: 1978728
    [Abstract] [Full Text] [Related]

  • 8. 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
    Schmidt CJ, Taylor VL, Abbate GM, Nieduzak TR.
    J Pharmacol Exp Ther; 1991 Jan 22; 256(1):230-5. PubMed ID: 1899117
    [Abstract] [Full Text] [Related]

  • 9. 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
    Huang X, Nichols DE.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):291-6. PubMed ID: 8104811
    [Abstract] [Full Text] [Related]

  • 10. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
    Nash JF, Yamamoto BK.
    Brain Res; 1992 May 29; 581(2):237-43. PubMed ID: 1356579
    [Abstract] [Full Text] [Related]

  • 11. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
    Schmidt CJ, Black CK, Abbate GM, Taylor VL.
    Brain Res; 1990 Oct 08; 529(1-2):85-90. PubMed ID: 1980848
    [Abstract] [Full Text] [Related]

  • 12. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR.
    Br J Pharmacol; 2002 Jan 08; 135(1):170-80. PubMed ID: 11786492
    [Abstract] [Full Text] [Related]

  • 13. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
    Ball KT, Rebec GV.
    Psychopharmacology (Berl); 2005 Oct 08; 181(4):676-87. PubMed ID: 16001122
    [Abstract] [Full Text] [Related]

  • 14. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
    Nair SG, Gudelsky GA.
    Brain Res; 2004 Jul 09; 1013(2):168-73. PubMed ID: 15193525
    [Abstract] [Full Text] [Related]

  • 15. MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.
    Fischer HS, Zernig G, Schatz DS, Humpel C, Saria A.
    Eur J Neurosci; 2000 Apr 09; 12(4):1385-90. PubMed ID: 10762366
    [Abstract] [Full Text] [Related]

  • 16. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates.
    Hiramatsu M, DiStefano E, Chang AS, Cho AK.
    Eur J Pharmacol; 1991 Nov 05; 204(2):135-40. PubMed ID: 1725282
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.
    Gudelsky GA, Yamamoto BK, Nash JF.
    Eur J Pharmacol; 1994 Nov 03; 264(3):325-30. PubMed ID: 7698172
    [Abstract] [Full Text] [Related]

  • 18. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
    O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR, Colado MI.
    Neuropsychopharmacology; 2005 Jul 03; 30(7):1312-23. PubMed ID: 15688085
    [Abstract] [Full Text] [Related]

  • 19. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study.
    Hiramatsu M, Cho AK.
    Neuropharmacology; 1990 Mar 03; 29(3):269-75. PubMed ID: 1691459
    [Abstract] [Full Text] [Related]

  • 20. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD, Nichols DE, Yim GK.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.